Skip to main content
Erschienen in: Reactions Weekly 1/2018

01.11.2018 | Case report

Ceritinib

Cholestasis with dilation of intrahepatic bile duct: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Hirano T, et al. Possible involvement of interleukin-18 in the pathology of hepatobiliary adverse effects related to treatment with ceritinib 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis. BMC Cancer 18: 995, No. 1, 19 Oct 2018. Available from: URL: http://doi.org/10.1186/s12885-018-4913-5 -Japan Hirano T, et al. Possible involvement of interleukin-18 in the pathology of hepatobiliary adverse effects related to treatment with ceritinib 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis. BMC Cancer 18: 995, No. 1, 19 Oct 2018. Available from: URL: http://​doi.​org/​10.​1186/​s12885-018-4913-5 -Japan
Metadaten
Titel
Ceritinib
Cholestasis with dilation of intrahepatic bile duct: case report
Publikationsdatum
01.11.2018
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-018-54356-2

Weitere Artikel der Ausgabe 1/2018

Reactions Weekly 1/2018 Zur Ausgabe

Case report

Multiple drugs

Case report

Ciclosporin

Case report

Cilostazol